Cognoa is one step closer in its effort to get the first US Food and Drug Administration-cleared medical device for early diagnosis of autistic spectrum disorder (ASD) to market.
The Palo Alto, CA-based company announced on 23 September it will be submitting its artificial-intelligence-powered digital app for early detection...